Sientra, Inc. (NASDAQ:SIEN) has been given an average rating of “Hold” by the seven ratings firms that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $13.75.

A number of research analysts recently issued reports on the company. Lake Street Capital reiterated a “buy” rating and issued a $15.00 target price (up from $11.00) on shares of Sientra in a report on Tuesday, August 8th. Stifel Nicolaus reiterated a “hold” rating and issued a $14.00 target price (up from $11.00) on shares of Sientra in a report on Wednesday, September 27th. Zacks Investment Research lowered Sientra from a “hold” rating to a “sell” rating in a report on Tuesday, August 15th. Canaccord Genuity reiterated a “buy” rating and issued a $14.00 target price on shares of Sientra in a report on Sunday, October 8th. Finally, William Blair upgraded Sientra from a “market perform” rating to an “outperform” rating in a report on Wednesday, September 13th.

ILLEGAL ACTIVITY WARNING: This news story was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/11/02/sientra-inc-sien-given-consensus-rating-of-hold-by-brokerages.html.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Gilder Gagnon Howe & Co. LLC lifted its holdings in Sientra by 36.3% during the 2nd quarter. Gilder Gagnon Howe & Co. LLC now owns 1,114,511 shares of the medical instruments supplier’s stock worth $10,833,000 after buying an additional 296,902 shares during the last quarter. Vanguard Group Inc. lifted its holdings in Sientra by 11.2% during the 2nd quarter. Vanguard Group Inc. now owns 590,311 shares of the medical instruments supplier’s stock worth $5,737,000 after buying an additional 59,546 shares during the last quarter. Cloverdale Capital Management LLC lifted its holdings in Sientra by 28.9% during the 2nd quarter. Cloverdale Capital Management LLC now owns 492,237 shares of the medical instruments supplier’s stock worth $4,785,000 after buying an additional 110,495 shares during the last quarter. Bamco Inc. NY lifted its holdings in Sientra by 109.3% during the 2nd quarter. Bamco Inc. NY now owns 471,500 shares of the medical instruments supplier’s stock worth $4,583,000 after buying an additional 246,183 shares during the last quarter. Finally, Schroder Investment Management Group lifted its holdings in Sientra by 3.5% during the 2nd quarter. Schroder Investment Management Group now owns 432,461 shares of the medical instruments supplier’s stock worth $4,199,000 after buying an additional 14,728 shares during the last quarter. 77.59% of the stock is owned by institutional investors.

Sientra (NASDAQ:SIEN) last released its earnings results on Wednesday, August 9th. The medical instruments supplier reported ($0.55) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.59) by $0.04. The firm had revenue of $8.20 million during the quarter, compared to analyst estimates of $6.97 million. Sientra had a negative return on equity of 52.30% and a negative net margin of 173.83%. Sientra’s revenue for the quarter was up 32.3% on a year-over-year basis.

Sientra Company Profile

Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.

Analyst Recommendations for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra Inc. and related companies with MarketBeat.com's FREE daily email newsletter.